Stroke $STOK Therapeutics IPOs For Dravet Syndrome Cure
Behind The Bid
English - June 19, 2019 12:55 - 11 minutes - 15.5 MB - ★★★★★ - 2 ratingsInvesting Business Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Ripple Proposes 💍to Moneygram $MGI in Crypto Wedding
Next Episode: Tech + Cannabis: Akerna $KERN Jumps 300%
STOK stock will be listed today, IPOing at $18, market cap of ~$550mm. They have a drug for treating Dravet Syndrome which is in in Phase 3 trials.
Show notes:
~greetings and salutations~
$STOK: Stroke Therapeutics
$ADBE: Adobe
$AXTA: Axalta Coating
~intermission~
$IRWD: Ironwood Pharma
$MLNT: Melinta
~fin~